GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (NAS:BIMI) » Definitions » Beneish M-Score

BIMI International Medical (BIMI International Medical) Beneish M-Score : -3.35 (As of May. 02, 2024)


View and export this data going back to 2006. Start your Free Trial

What is BIMI International Medical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.35 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for BIMI International Medical's Beneish M-Score or its related term are showing as below:

BIMI' s Beneish M-Score Range Over the Past 10 Years
Min: -8.28   Med: -2.64   Max: 6.66
Current: -3.35

During the past 13 years, the highest Beneish M-Score of BIMI International Medical was 6.66. The lowest was -8.28. And the median was -2.64.


BIMI International Medical Beneish M-Score Historical Data

The historical data trend for BIMI International Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Beneish M-Score Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -2.36 -3.88

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.91 -3.88 -4.90 -3.36 -3.35

Competitive Comparison of BIMI International Medical's Beneish M-Score

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI International Medical's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Beneish M-Score falls into.



BIMI International Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of BIMI International Medical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.2987+0.528 * -0.2303+0.404 * 0.6555+0.892 * 1.9161+0.115 * 0.4176
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6199+4.679 * -0.058046-0.327 * 0.9351
=-3.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Total Receivables was $5.40 Mil.
Revenue was 2.523 + 5.558 + 3.198 + 1.354 = $12.63 Mil.
Gross Profit was 0.115 + 2.884 + 1.69 + 0.402 = $5.09 Mil.
Total Current Assets was $24.37 Mil.
Total Assets was $35.04 Mil.
Property, Plant and Equipment(Net PPE) was $4.58 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.25 Mil.
Selling, General, & Admin. Expense(SGA) was $8.98 Mil.
Total Current Liabilities was $20.16 Mil.
Long-Term Debt & Capital Lease Obligation was $2.47 Mil.
Net Income was -3.129 + 1.054 + -0.884 + -9.225 = $-12.18 Mil.
Non Operating Income was 0.051 + -0.091 + -1.406 + -5.804 = $-7.25 Mil.
Cash Flow from Operations was -1.484 + -0.57 + 2.818 + -3.664 = $-2.90 Mil.
Total Receivables was $9.44 Mil.
Revenue was 4.932 + 2.829 + 2.715 + -3.883 = $6.59 Mil.
Gross Profit was 0.703 + 0.473 + 0.372 + -2.16 = $-0.61 Mil.
Total Current Assets was $17.38 Mil.
Total Assets was $33.00 Mil.
Property, Plant and Equipment(Net PPE) was $6.86 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.15 Mil.
Selling, General, & Admin. Expense(SGA) was $7.56 Mil.
Total Current Liabilities was $18.90 Mil.
Long-Term Debt & Capital Lease Obligation was $3.89 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.401 / 12.633) / (9.438 / 6.593)
=0.427531 / 1.431518
=0.2987

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-0.612 / 6.593) / (5.091 / 12.633)
=-0.092826 / 0.402992
=-0.2303

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (24.367 + 4.579) / 35.041) / (1 - (17.384 + 6.861) / 33.003)
=0.173939 / 0.26537
=0.6555

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12.633 / 6.593
=1.9161

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.151 / (0.151 + 6.861)) / (0.249 / (0.249 + 4.579))
=0.021535 / 0.051574
=0.4176

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.984 / 12.633) / (7.564 / 6.593)
=0.711153 / 1.147277
=0.6199

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.471 + 20.158) / 35.041) / ((3.894 + 18.899) / 33.003)
=0.645786 / 0.690634
=0.9351

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-12.184 - -7.25 - -2.9) / 35.041
=-0.058046

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

BIMI International Medical has a M-score of -3.35 suggests that the company is unlikely to be a manipulator.


BIMI International Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (BIMI International Medical) Business Description

Traded in Other Exchanges
N/A
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.
Executives
Ang Sammi Ean Seok director 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709
Fnu Oudom director 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618
Xiaoping Wang director ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037
Baiqun Zhong officer: CFO 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039
Zhang Tingting director, officer: Chief Financial Officer 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Song Tiewei director 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Yongquan Bi 10 percent owner ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001
Wang Lihua director, 10 percent owner, officer: Chief Financial Officer NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003
Li Gang director, 10 percent owner, officer: President and CEO 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000
Jiuding Yan director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Lesley Jin director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Maclean John Coleman director 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501
Zhongmin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Jianxin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021
Mia Kuang Ching director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021

BIMI International Medical (BIMI International Medical) Headlines